Local and central testing for HER2, PD-L1, MSI/MMR, EBV, and CLDN18.2 in advanced gastric cancer: results from the SAPHIR registry.

Potthoff K, Bläker H, Dechow T, Binninger A, Ringwald K, de Buhr R, von der Heyde E, Zahn M.-O., Nusch A, Dörfel S, Schulz H, Haffner I, Höhn A.K., Monecke A, Lorenzen S, Reinacher-Schick A, Jänicke M, Lordick F.

ESMO Real World Data Digit Oncol. 2025 June; Volume 8: 100144. doi:10.1016/j.esmorw.2025.100144. Epub 2025 Apr 29.

Abstract